| Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites JA Downs, S Allard, O Jobin-Robitaille, A Javaheri, A Auger, N Bouchard, ... Molecular cell 16 (6), 979-990, 2004 | 691 | 2004 |
| Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure KC Bedi Jr, NW Snyder, J Brandimarto, M Aziz, C Mesaros, AJ Worth, ... Circulation 133 (8), 706-716, 2016 | 530 | 2016 |
| Role of Dot1-Dependent Histone H3 Methylation in G1 and S Phase DNA Damage Checkpoint Functions of Rad9 R Wysocki, A Javaheri, S Allard, F Sha, J Côté, SJ Kron Molecular and cellular biology 25 (19), 8430-8443, 2005 | 354 | 2005 |
| Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis I Sergin, TD Evans, X Zhang, S Bhattacharya, CJ Stokes, E Song, S Ali, ... Nature communications 8 (1), 15750, 2017 | 283 | 2017 |
| Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial MN Kosiborod, R Esterline, RHM Furtado, J Oscarsson, SB Gasparyan, ... The lancet Diabetes & endocrinology 9 (9), 586-594, 2021 | 199 | 2021 |
| Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway H Liu, A Javaheri, RJ Godar, J Murphy, X Ma, N Rohatgi, J Mahadevan, ... Autophagy 13 (11), 1952-1968, 2017 | 177 | 2017 |
| γ-H2AX as a therapeutic target for improving the efficacy of radiation therapy J Kao, MT Milano, A Javaheri, MC Garofalo, SJ Chmura, ... Current cancer drug targets 6 (3), 197-205, 2006 | 108 | 2006 |
| Yeast G1 DNA damage checkpoint regulation by H2A phosphorylation is independent of chromatin remodeling A Javaheri, R Wysocki, O Jobin-Robitaille, M Altaf, J Côté, SJ Kron Proceedings of the National Academy of Sciences 103 (37), 13771-13776, 2006 | 106 | 2006 |
| Sleep apnea, heart failure, and pulmonary hypertension S Javaheri, S Javaheri, A Javaheri Current heart failure reports 10, 315-320, 2013 | 97 | 2013 |
| Proteomic signatures of heart failure in relation to left ventricular ejection fraction L Adamo, J Yu, C Rocha-Resende, A Javaheri, RD Head, DL Mann Journal of the American College of Cardiology 76 (17), 1982-1994, 2020 | 67 | 2020 |
| Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the … M Kosiborod, O Berwanger, GG Koch, F Martinez, O Mukhtar, S Verma, ... Diabetes, Obesity and Metabolism 23 (4), 886-896, 2021 | 62 | 2021 |
| CDK Pho85 targets CDK inhibitor Sic1 to relieve yeast G1 checkpoint arrest after DNA damage R Wysocki, A Javaheri, K Kristjansdottir, F Sha, SJ Kron Nature structural & molecular biology 13 (10), 908-914, 2006 | 59 | 2006 |
| Reduced apolipoprotein M and adverse outcomes across the spectrum of human heart failure JA Chirinos, L Zhao, Y Jia, C Frej, L Adamo, D Mann, SV Shewale, ... Circulation 141 (18), 1463-1476, 2020 | 55 | 2020 |
| Transcription Factor EB activation rescues advanced αB‐crystallin mutation‐induced cardiomyopathy by normalizing desmin localization X Ma, K Mani, H Liu, A Kovacs, JT Murphy, L Foroughi, BA French, ... Journal of the American Heart Association 8 (4), e010866, 2019 | 48 | 2019 |
| TFEB activation in macrophages attenuates postmyocardial infarction ventricular dysfunction independently of ATG5-mediated autophagy A Javaheri, G Bajpai, A Picataggi, S Mani, L Foroughi, H Evie, A Kovacs, ... JCI insight 4 (21), 2019 | 43 | 2019 |
| Lack of MTTP activity in pluripotent stem cell-derived hepatocytes and cardiomyocytes abolishes apoB secretion and increases cell stress Y Liu, DM Conlon, X Bi, KJ Slovik, J Shi, HI Edelstein, JS Millar, ... Cell Reports 19 (7), 1456-1466, 2017 | 43 | 2017 |
| Metabolomic profiling of the effects of dapagliflozin in heart failure with reduced ejection fraction: DEFINE-HF S Selvaraj, Z Fu, P Jones, LC Kwee, SL Windsor, O Ilkayeva, CB Newgard, ... Circulation 146 (11), 808-818, 2022 | 41 | 2022 |
| Proteasomal degradation of TRAF2 mediates mitochondrial dysfunction in doxorubicin-cardiomyopathy R Dhingra, I Rabinovich-Nikitin, S Rothman, M Guberman, H Gang, ... Circulation 146 (12), 934-954, 2022 | 28 | 2022 |
| Quantitative proteomic analysis of diabetes mellitus in heart failure with preserved ejection fraction TC Hanff, JB Cohen, L Zhao, A Javaheri, P Zamani, SB Prenner, ... Basic to Translational Science 6 (2), 89-99, 2021 | 21 | 2021 |
| Lysosomes mediate benefits of intermittent fasting in cardiometabolic disease: the janitor is the undercover boss. K Mani, A Javaheri, A Diwan Comprehensive Physiology 8 (4), 1639, 2018 | 21 | 2018 |
Abhinav DiwanProfessor of Medicine, Cell Biology and PhysiologyDirección de correo verificada de dom.wustl.edu
